Argenx Se ARGX
NASDAQ ARGX
$962.22 +16.40 (+1.73%)
At close: Sep 24, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Non Operating Interest Expenses (2019 - 2026)

Argenx Se's (ARGX) quarterly Non Operating Interest Expenses came in at -$1.0 million in Q2 2026, up 11.19% on a YoY basis from -$899361.0 in Q2 2025, and little changed quarter-over-quarter from -$1.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Non Operating Interest Expenses for 8 consecutive years, with -$1.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non Operating Interest Expenses rose 11.19% year-over-year to -$1.0 million; the trailing twelve-month figure through Jun 2026 stood at -$3.8 million (down 8.98% YoY), and the FY2025 full-year result was -$4.1 million, down 65.67% from the prior year.
  • Non Operating Interest Expenses held at -$1.0 million in Q2 2026 per ARGX's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Non Operating Interest Expenses topped out at -$188000.0 in Q1 2023 and bottomed at -$1.2 million in Q2 2022.
  • Historically, Non Operating Interest Expenses has averaged -$734611.1 across 5 years, with a median of -$806500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses surged 82.43% in 2023, then tumbled 192.64% in 2024.
  • Over 5 years, Non Operating Interest Expenses stood at -$990000.0 in 2022, then surged by 71.72% to -$280000.0 in 2023, then plunged by 151.43% to -$704000.0 in 2024, then retreated by 17.61% to -$828000.0 in 2025, then retreated by 20.77% to -$1.0 million in 2026.
  • According to Business Quant data, Non Operating Interest Expenses over the past three periods registered -$1.0 million, -$1.0 million, and -$828000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 281.00 Mn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -435.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 247.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Argenx Se 58.53 Bn 53.35 Bn 1.37 Bn -1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.00 Mn
Mar 31, 2026 -1.00 Mn
Dec 31, 2025 -828,000.00
Sep 30, 2025 -993,000.00
Jun 30, 2025 -1.13 Mn
Mar 31, 2025 -1.00 Mn
Dec 31, 2024 -704,000.00
Sep 30, 2024 -676,000.00
Jun 30, 2024 -572,000.00
Mar 31, 2024 -512,000.00
Dec 31, 2023 -280,000.00
Sep 30, 2023 -231,000.00
Jun 30, 2023 -207,000.00
Mar 31, 2023 -188,000.00
Dec 31, 2022 -990,000.00
Sep 30, 2022 -785,000.00
Jun 30, 2022 -1.18 Mn
Mar 31, 2022 -953,000.00
Dec 31, 2021 -1.10 Mn
Sep 30, 2021 -1.10 Mn
API Access

Argenx Se Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ARGX&period=max&api_key=YOUR_API_KEY